AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets close in 2 hrs 4 mins

Allergan plc (AGN)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
216.71+1.93 (+0.90%)
As of 1:56PM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close214.78
Bid0.00 x
Ask0.00 x
Day's Range214.70 - 218.99
52 Week Range184.50 - 301.98
Avg. Volume5,266,777
Market Cap81.28B
PE Ratio (TTM)6.08
Earnings DateN/A
Dividend & Yield2.80 (1.30%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com7 hours ago

    Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions

    The pharmaceutical company's new strategy emphasizes new product launches and international expansion.

  • Reuters13 hours ago

    PRESS DIGEST- Wall Street Journal - Jan 18

    The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - President Barack Obama shortened Chelsea Manning's 35-year ...

  • Reuters20 hours ago

    Allergan to pay $15 mln over failing to disclose merger talks

    A unit of Botox maker Allergan Plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the unit of failing to disclose 2014 merger talks with Actavis, the U.S. Securities and Exchange Commission said. In a statement on Tuesday, the SEC said that the disclosure failures occurred in the months after the company received a tender offer from Valeant Pharmaceuticals International and co-bidder Pershing Square Capital Management, the hedge fund run by Bill Ackman.